144 related articles for article (PubMed ID: 1419619)
61. Disposition of epirubicin in an oily contrast medium after intravenous and intrahepato-arterial administration in liver cancer: a preliminary report.
Lee K; Chan K; Leung WT; Leung NW; Ho S; Chan M; Lau CC; Tao M; Lau WY; Shiu W
Eur J Drug Metab Pharmacokinet; 1992; 17(3):221-6. PubMed ID: 1337040
[TBL] [Abstract][Full Text] [Related]
62. HeartMate II left ventricular assist device implantation in patients with advanced hepatic dysfunction.
Demirozu ZT; Hernandez R; Mallidi HR; Singh SK; Radovancevic R; Segura AM; Etheridge WB; Cohn WE; Frazier OH
J Card Surg; 2014 May; 29(3):419-23. PubMed ID: 24641429
[TBL] [Abstract][Full Text] [Related]
63. Abnormalities of liver function and the predictive value of liver function tests in infection and outcome of acutely ill elderly patients.
Kenny RA; Hodkinson HM; Prendiville OF; Hayes MC; Flynn MD
Age Ageing; 1984 Jul; 13(4):224-9. PubMed ID: 6475651
[TBL] [Abstract][Full Text] [Related]
64. Regression of hepatic steatosis in morbidly obese persons after gastric bypass.
Silverman EM; Sapala JA; Appelman HD
Am J Clin Pathol; 1995 Jul; 104(1):23-31. PubMed ID: 7611176
[TBL] [Abstract][Full Text] [Related]
65. Changes in liver enzymes after clinical islet transplantation.
Rafael E; Ryan EA; Paty BW; Oberholzer J; Imes S; Senior P; McDonald C; Lakey JR; Shapiro AM
Transplantation; 2003 Nov; 76(9):1280-4. PubMed ID: 14627903
[TBL] [Abstract][Full Text] [Related]
66. Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer.
Robert J; Vrignaud P; Nguyen-Ngoc T; Iliadis A; Mauriac L; Hurteloup P
Cancer Treat Rep; 1985 Jun; 69(6):633-40. PubMed ID: 3893693
[TBL] [Abstract][Full Text] [Related]
67. Serum hepatic biochemical activity in two populations of workers exposed to styrene.
Brodkin CA; Moon JD; Camp J; Echeverria D; Redlich CA; Willson RA; Checkoway H
Occup Environ Med; 2001 Feb; 58(2):95-102. PubMed ID: 11160987
[TBL] [Abstract][Full Text] [Related]
68. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
Gordin FM; Cohn DL; Matts JP; Chaisson RE; O'Brien RJ; ; ;
Clin Infect Dis; 2004 Aug; 39(4):561-5. PubMed ID: 15356822
[TBL] [Abstract][Full Text] [Related]
69. [Study on the damage of liver in patients with SARS].
Guan YJ; Tang XP; Yin CB; Yi ZQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
[TBL] [Abstract][Full Text] [Related]
70. Usefulness of liver function tests in postmortem samples.
Fumeaux L; Scarpelli MP; Tettamanti C; Palmiere C
J Forensic Leg Med; 2018 May; 56():51-54. PubMed ID: 29533205
[TBL] [Abstract][Full Text] [Related]
71. Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety.
Guo F; Letrent SP; Munster PN; Britten CD; Gelmon K; Tolcher AW; Sharma A
Cancer Chemother Pharmacol; 2008 Jun; 62(1):97-109. PubMed ID: 17805538
[TBL] [Abstract][Full Text] [Related]
72. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
[TBL] [Abstract][Full Text] [Related]
73. Serum bile acid: an alternative liver function marker in the obstructive jaundice patient.
Lalisang TJ
Acta Med Indones; 2012 Jul; 44(3):233-8. PubMed ID: 22983079
[TBL] [Abstract][Full Text] [Related]
74. Unexplained high AST in locally advanced breast cancer.
Birtle A; Lawton P; Chaundary M; Richman P; Mcfarlane B
Breast J; 2003; 9(6):505-6. PubMed ID: 14616949
[No Abstract] [Full Text] [Related]
75. Renal and liver function tests in surgical septicemia.
Smith-Erichsen N
Acta Anaesthesiol Scand; 1987 Apr; 31(3):208-13. PubMed ID: 3577643
[TBL] [Abstract][Full Text] [Related]
76. Is preoperative ultrasound cancer survey necessary in patients with normal liver function tests?
Lin HH; Lin DY
J Clin Gastroenterol; 1991 Feb; 13(1):108-10. PubMed ID: 2007729
[TBL] [Abstract][Full Text] [Related]
77. Multivariate analysis of clinical and biological data in cirrhotic patients: application to prognosis.
Ekindjian OG; Devanlay M; Duchassaing D; Leluan G; Kammerer J; Fouet P; Auget JL; Maccario J
Eur J Clin Invest; 1981 Jun; 11(3):213-20. PubMed ID: 6791941
[TBL] [Abstract][Full Text] [Related]
78. The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination.
Van den Berg HW; Desai ZR; Wilson R; Kennedy G; Bridges JM; Shanks RG
Cancer Chemother Pharmacol; 1982; 8(2):215-9. PubMed ID: 7105384
[TBL] [Abstract][Full Text] [Related]
79. Liver function studies. Part I: introduction and bilirubin.
Byrne J
Nursing; 1977 Jul; 7(7):12-4. PubMed ID: 586505
[No Abstract] [Full Text] [Related]
80. [Evaluation of the diazoreaction of serum bilirubin].
MONCKE C
Klin Wochenschr; 1952 Apr; 30(13-14):319-23. PubMed ID: 14946939
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
